Monthly Archives: May 2021

Releviate Therapeutics Appoints Jennifer Maynard to Its Scientific Advisory Board As One of the Pharmaceutical Industry’s Leading Antibody Specialists, Maynard Brings Releviate Therapeutics Over 20 Years of Experience in Antibody Therapeutics SAN DIEGO – May 4, 2021 – Releviate™ Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from neuropathic pain, today welcomes